Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-27T02:42:51.626Z Has data issue: false hasContentIssue false
  • English
  • Français

Characterization of the intramuscular pharmacokinetics of ziprasidone in schizophrenic patients

Published online by Cambridge University Press:  16 April 2020

J. Miceli ,
S. Preskorn ,
K. Wilner ,
C. Folger  and
T. Tensfeld
J. Miceli
Affiliation:
Central Research Division, Pfizer Inc, Groton, CT06340
S. Preskorn
Affiliation:
Psychiatric Research Institute, Wichita, KS67214, USA
K. Wilner
Affiliation:
Central Research Division, Pfizer Inc, Groton, CT06340
C. Folger
Affiliation:
Central Research Division, Pfizer Inc, Groton, CT06340
T. Tensfeld
Affiliation:
Central Research Division, Pfizer Inc, Groton, CT06340

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 304s - 305s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.